Immunotherapy Market Share, Trends, Future Outlook, Analysis and Forecast 2023-2030

The global immunotherapy market is anticipated to grow at a considerable CAGR of 13.8% during the forecast period. The market growth is mainly driven by increasing auto-immune diseases among adults, growing in monoclonal body production for treatment of cancer, rising approvals for immunotherapies, increasing investments in research and funding of cancer among others. Rising R&D activities in field of the cancer immunotherapy is playing a crucial role in beginning of advanced variants along with elevated efficacy and treatment effectiveness. The R&D in this field will support to medical professionals tomake a shift from chemotherapies that is a traditional one to immunotherapies which is more advanced form of cancer treatment. Therefore, increasing adoption of immunotherapy in replacement of chemotherapy is used to drive the growth of the immunotherapy market..Due to the large scale adoption of sedentary lifestyle, smoking along with alcohol habits are accountable for growing incidence related to cancer. The rising cancer population is creating demand for its treatment; the efficiency of immunotherapy is thus driving the growth of the global immunotherapy market. Additionally, other factors such as technological breakthroughs along with strategic collaborations are again augmenting the growth and development of the market. For instance, in October 2020, Aduro biotech, Inc. had acquired Chinook therapeutics. Aduro biotech, Inc. which emphasis on diseases treatment through discovery, development and commercialization of therapies that will result in harness the body's natural immune systems while Chinook therapeutics focuses on medicines related to diseases for kidney with particularly emplacing on rare and severe disorders. Through these mergers it will add BION-1301 an investigational anti-APRIL monoclonal antibody which is in its pipeline.

A full report of Immunotherapy Market is available at: https://www.omrglobal.com/industry-reports/immunotherapy-market

Market Coverage

The market number available for - 2020-2027
Base year- 2020
Forecast period- 2021-2027
Segment Covered-
o By Type

o By Application

o By End-User

Regions Covered-
o North America

o Europe

o Asia-Pacific

o Rest of the World

Competitive Landscape-AbbVie Inc,AstraZeneca,Bristol-Myers Squibb Company,Novartis AG,Merck & Co., Inc.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/immunotherapy-market

Key questions addressed by the report

What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

Who is the leader in the market?
How players are addressing challenges to sustain growth?
Where is the investment opportunity?

Global Immunotherapy Market Report Segment

By Type

Monoclonal Antibodies
Cancer Vaccines
Autoimmune Checkpoint Inhibitors
Interleukins and Interferons (Cytokinin's)
Other

By Application

Cancer
Autoimmune and Inflammatory Diseases
Infectious Diseases
Other

By End-User

Hospitals
Diagnostic Centers
Other

Immunotherapy Market- Segment by Region

North America

United States
Canada

Europe

Germany
United Kingdom
France
Spain
Italy
Rest of Europe

Asia-Pacific

China
Japan
India
Rest of Asia-Pacific

Rest of the World

Middle East & Africa
Latin America

Company Profiles

Advaxis, Inc.
AbbVie Inc.
AstraZeneca PLC
Adaptimmune Therapeutics plc.
Agenus, Inc.
Atara Biotherapeutics, Inc.
BellicumPhamaceuticals, Inc.
Bristol-Myers Squibb Company
bluebird bio, Inc.
Chinook Therapeutics, Inc.
Celldex Therapeutics, Inc.
CytomX Therapeutics, Inc.
Gilead Sciences, Inc.
Incyte Corp.

Reasons to Buying From us -

We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.